The incidence of cardiac complications in patients hospitalised with COVID-19 in Australia: the AUS-COVID study

Med J Aust. 2021 Sep 20;215(6):279. doi: 10.5694/mja2.51225. Epub 2021 Aug 17.

Authors

Kunwardeep S Bhatia¹, William van Gaal², Leonard Kritharides^{3

4}, Clara K Chow^{5

6}, Ravinay Bhindi^{1

7}; AUS-COVID Investigators

Affiliations

¹ Royal North Shore Hospital, Sydney, NSW.
² Northern Health, Melbourne, VIC.
³ Concord Repatriation General Hospital, Sydney, NSW.
⁴ ANZAC Research Institute, Sydney, NSW.
⁵ Westmead Clinical School, University of Sydney, Sydney, NSW.
⁶ Westmead Hospital, Sydney, NSW.
⁷ Northern Clinical School, University of Sydney, Sydney, NSW.

No abstract available

Keywords: Atrial fibrillation; COVID-19; Cardiomyopathies.

Publication types

Letter
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Atrial Fibrillation / epidemiology*
Atrial Fibrillation / immunology
Atrial Fibrillation / virology
Australia / epidemiology
COVID-19 / complications*
COVID-19 / immunology
COVID-19 / therapy
COVID-19 / virology
Cardiomyopathies / epidemiology*
Cardiomyopathies / immunology
Cardiomyopathies / virology
Female
Heart Failure / epidemiology*
Heart Failure / immunology
Heart Failure / virology
Hospitalization / statistics & numerical data
Humans
Incidence
Male
Middle Aged
Pericarditis / epidemiology*
Pericarditis / immunology
Pericarditis / virology
Prospective Studies
Registries / statistics & numerical data
SARS-CoV-2 / immunology
SARS-CoV-2 / pathogenicity

Grants and funding